Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by N. Krämer
P13 Impact of ErbB Mutations on Clinical Outcomes in Afatinib- Or Erlotinib-Treated Patients With SCC of the Lung
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Related publications
P1.01-110 Three Specific HER2 Mutations Predict Favorable Outcomes in Advanced Lung Cancer Patients Treated With Afatinib
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P088 Distribution of Different HER2 Mutations and Their Impact on Clinical Responses to Afatinib in HER2-Mutant Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Synergistic Effect of Afatinib With Su11274 in Non-Small Cell Lung Cancer Cells Resistant to Gefitinib or Erlotinib
PLoS ONE
Multidisciplinary
The Impact of Initial Gefitinib or Erlotinib Versus Chemotherapy on Central Nervous System Progression in Advanced Non-Small Cell Lung Cancer With EGFR Mutations
Clinical Cancer Research
Cancer Research
Oncology
KRAS Mutations and Primary Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib
PLoS Medicine
Biochemistry
Biotechnology
Molecular Biology
Cell Biology
Medicine
Clinical Outcomes of Patients With ACS Treated With Prasugrel
Heart Lung and Circulation
Respiratory Medicine
Pulmonary
Cardiovascular Medicine
Cardiology
Clinical Analysis of EGFR‐ Positive Non‐small Cell Lung Cancer Patients Treated With First‐line Afatinib: A Nagano Lung Cancer Research Group
Thoracic Cancer
Medicine
Pulmonary
Respiratory Medicine
Oncology
Prognostic Impact of [18F]Fluorothymidine and [18F]Fluoro-D-Glucose Baseline Uptakes in Patients With Lung Cancer Treated First-Line With Erlotinib
PLoS ONE
Multidisciplinary
Next-Generation Sequencing and Clinical Outcomes of Patients With Lung Adenocarcinoma Treated With Stereotactic Body Radiotherapy
Cancer
Cancer Research
Oncology
